A detailed history of Ivc Wealth Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Ivc Wealth Advisors LLC holds 1,473 shares of AMGN stock, worth $457,926. This represents 0.24% of its overall portfolio holdings.

Number of Shares
1,473
Previous 1,490 1.14%
Holding current value
$457,926
Previous $429,000 2.56%
% of portfolio
0.24%
Previous 0.27%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$268.87 - $324.56 $4,570 - $5,517
-17 Reduced 1.14%
1,473 $418,000
Q4 2023

Jan 10, 2024

SELL
$255.7 - $288.46 $18,921 - $21,346
-74 Reduced 4.73%
1,490 $429,000
Q3 2023

Oct 05, 2023

BUY
$218.65 - $271.46 $5,028 - $6,243
23 Added 1.49%
1,564 $420,000
Q2 2023

Jul 13, 2023

BUY
$214.27 - $253.37 $2,785 - $3,293
13 Added 0.85%
1,541 $342,000
Q1 2023

Apr 13, 2023

SELL
$225.79 - $275.2 $225 - $275
-1 Reduced 0.07%
1,528 $369,000
Q4 2022

Jan 17, 2023

SELL
$229.03 - $291.01 $1,374 - $1,746
-6 Reduced 0.39%
1,529 $0
Q3 2022

Oct 12, 2022

SELL
$224.46 - $253.15 $224 - $253
-1 Reduced 0.07%
1,535 $346,000
Q2 2022

Jul 11, 2022

BUY
$230.71 - $256.74 $2,768 - $3,080
12 Added 0.79%
1,536 $374,000
Q1 2022

Apr 27, 2022

SELL
$219.27 - $242.57 $6,578 - $7,277
-30 Reduced 1.93%
1,524 $369,000
Q4 2021

Jan 13, 2022

BUY
$198.88 - $227.6 $22,075 - $25,263
111 Added 7.69%
1,554 $350,000
Q3 2021

Oct 08, 2021

SELL
$212.27 - $248.7 $52,855 - $61,926
-249 Reduced 14.72%
1,443 $307,000
Q2 2021

Jul 13, 2021

BUY
$233.58 - $259.14 $467 - $518
2 Added 0.12%
1,692 $412,000
Q1 2021

Apr 20, 2021

BUY
$221.91 - $258.6 $221 - $258
1 Added 0.06%
1,690 $421,000
Q4 2020

Feb 01, 2021

BUY
$216.38 - $257.67 $365,465 - $435,204
1,689 New
1,689 $388,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ivc Wealth Advisors LLC Portfolio

Follow Ivc Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ivc Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ivc Wealth Advisors LLC with notifications on news.